Continuous arteriovenous hemofiltration attenuates polymorphonuclear leukocyte phagocytosis in porcine intra-abdominal sepsis

被引:16
作者
DiScipio, AW [1 ]
Burchard, KW [1 ]
机构
[1] DARTMOUTH HITCHCOCK MED CTR,SECT GEN SURG,DEPT SURG,LEBANON,NH 03756
关键词
D O I
10.1016/S0002-9610(97)89590-6
中图分类号
R61 [外科手术学];
学科分类号
摘要
BACKGROUND: Activation of circulating polymorphonuclear leukocytes (PMN) is a characteristic of systemic inflammation and may contribute to organ malfunction. Continuous arteriovenous hemofiltration (CAVH) has been reported to improve organ malfunction during severe systemic inflammation. This study postulates that the CAVH effects may be linked to alterations in PMN activation. METHODS: Sixteen pigs that underwent cecal ligation and rupture were randomized to receive CAVH or no CAVH for 24 hours. The PMN phagocytosis of Candida was measured prior to the insult and at 24, 48, and 72 hours. Temperature, total leukocyte count (WBC), hemodynamic, blood gas, microbiologic, and ionized calcium data were also collected. RESULTS: All animals developed increased temperature, heart rate, and WBC, and positive blood and peritoneal cultures. Hemodynamic, pulmonary, and ionized calcium changes were not different between the CAVH and no CAVH groups. Phagocytosis of PMN increased in the no CAVH group at 24 hours, but not in the CAVH group. After discontinuing CAVH, phagocytosis increased to the no CAVH rate at 48 and 72 hours. CONCLUSIONS: Continuous arteriovenous hemofiltration attenuates the upregulation of PMN phagocytosis of Candida; this effect disappears after CAVH is discontinued. Hemofiltration does not affect many other manifestations of sepsis, which implies that these manifestations may not be related to PMN phagocytosis capacity. (C) 1997 by Excerpta Medica, Inc.
引用
收藏
页码:174 / 180
页数:7
相关论文
共 28 条
[1]  
American College of Chest Physicians/Society of Critical Care Medicine Consensus Conference, 1992, CRIT CARE MED, V6, P864
[2]  
[Anonymous], 1986, Laboratory manual of neutrophil Function
[3]   USE OF EXTRACORPOREAL SUPPORTIVE TECHNIQUES AS ADDITIONAL TREATMENT FOR SEPTIC-INDUCED MULTIPLE ORGAN FAILURE PATIENTS [J].
BARZILAY, E ;
KESSLER, D ;
BERLOT, G ;
GULLO, A ;
GEBER, D ;
BENZEEV, I .
CRITICAL CARE MEDICINE, 1989, 17 (07) :634-637
[4]  
BAUE AE, 1992, ARCH SURG-CHICAGO, V127, P1451
[5]   CONTINUOUS VENOVENOUS HEMOFILTRATION WITH DIALYSIS REMOVES CYTOKINES FROM THE CIRCULATION OF SEPTIC PATIENTS [J].
BELLOMO, R ;
TIPPING, P ;
BOYCE, N .
CRITICAL CARE MEDICINE, 1993, 21 (04) :522-526
[6]   INHIBITORS OF COMPLEMENT AND NEUTROPHILS - A CRITICAL-EVALUATION OF THEIR ROLE IN THE TREATMENT OF SEPSIS [J].
BONE, RC .
CRITICAL CARE MEDICINE, 1992, 20 (06) :891-898
[7]  
CAREY PD, 1992, SURGERY, V112, P45
[8]   MULTIPLE ORGAN FAILURE - PATHOPHYSIOLOGY AND POTENTIAL FUTURE THERAPY [J].
DEITCH, EA .
ANNALS OF SURGERY, 1992, 216 (02) :117-134
[9]   PHAGOCYTOSIS BY LIPOPOLYSACCHARIDE-PRIMED HUMAN NEUTROPHILS IS ASSOCIATED WITH INCREASED EXTRACELLULAR RELEASE OF REACTIVE OXYGEN METABOLITES [J].
FOLLIN, P ;
DAHLGREN, C .
INFLAMMATION, 1992, 16 (02) :83-91
[10]  
GARNER CV, 1992, CRIT CARE MED, V20, pS102